Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
Jichuan Pharmaceutical: Chai Ge Antipyretic Oral Liquid Registration Application Accepted
Jichuan Pharmaceutical Co., Ltd. announced that its wholly owned subsidiary, Jichuan Limited, has received the “Acceptance Notice” issued by the National Medical Products Administration for the application to register for market listing of “Chai Ge Fever-Reducing Oral Liquid.” This medicine is a Class 1.1 traditional Chinese medicine, mainly used to treat symptoms such as fever and headache caused by wind-heat type common colds. As of now, the project has accumulated investment of 59.1456 million yuan. According to publicly available information, there is currently no information in China on drug listings or registration application submissions that match its prescription. This acceptance indicates that the domestic drug registration work for the product has entered the review stage, and the future market has room for development.